Gaithersburg, MD, United States of America

Ikbel Achour

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Medimmune Limited. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ikbel Achour. Retrieved from https://idiyas.com/inventor/ikbel-achour-4nkw9epi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ikbel Achour: Innovator in Cancer Treatment

Introduction

Ikbel Achour is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer treatment through his innovative methods. With a total of 2 patents, Achour is dedicated to improving patient outcomes in oncology.

Latest Patents

Achour's latest patents focus on methods for determining treatment for cancer patients. These methods are disclosed to enhance the precision of treatment plans tailored to individual patient needs. His work aims to provide better therapeutic options for those battling cancer.

Career Highlights

Ikbel Achour is currently employed at MedImmune Limited, a leading biotechnology company. His role involves research and development in the field of cancer therapies. Achour's expertise and innovative mindset have positioned him as a valuable asset in the medical community.

Collaborations

Throughout his career, Achour has collaborated with talented professionals, including Li Yu and Harry Yang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer treatment.

Conclusion

Ikbel Achour is a dedicated inventor whose work in cancer treatment is making a significant impact. His innovative methods and collaborations highlight his commitment to improving patient care. Achour's contributions to the field are paving the way for future advancements in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…